Rehabilitation of Stroke Patients for Maximal Neurological Restoration
Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Oct 18, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help stroke patients recover their ability to move their arms better. Researchers will use special imaging techniques, like MRI (a type of scan that takes detailed pictures of the brain) and EEG (which measures brain activity), to study how the brain is functioning after a stroke. They want to see if these imaging tools can help them understand the best ways to support recovery and improve motor skills in patients after a stroke.
To participate in this trial, individuals need to be between the ages of 65 and 74 and have experienced a specific kind of stroke that affects their arm movement. They must have been admitted to St. Olav's Hospital between 2021 and 2023. Unfortunately, people with a history of prior strokes, certain brain diseases, or conditions that interfere with MRI scans (like severe anxiety or cognitive issues) cannot join the study. Participants can expect to undergo several imaging tests and receive assessments of their motor skills throughout the study, contributing to important research aimed at improving recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subcortical strokes resulting in arm motor deficits.
- • admitted to the stroke unit, St Olav´s Hospital during 2021-2023
- Exclusion Criteria:
- • Previous stroke
- • neurodegenerative disease
- • brain tumors
- • previous neurotrauma or brain operation
- • aphasia
- • cognitive dysfunction and claustrophobia preventing MRI examinations.
About Norwegian University Of Science And Technology
The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Oslo, , Norway
Trondheim, , Norway
Patients applied
Trial Officials
Axel Sandvig, PhD prof
Principal Investigator
Norwegian University of Science and Technology
Jorunn Helbostad, PhD prof
Study Director
Norwegian University of Science and Technology
Bent Indredavik, PhD prof
Study Director
St. Olavs Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials